stockrowNeogen Corporation
NEOG Healthcare Medical Devices
Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.
- Revenue
- +6.50%
- EPS
- −129.4%
- Free cash flow
- +135.6%
- Total debt
- −2.31%
Quarter to August 2026, against a year earlier
Follow NEOG
Alert me
Neogen Corporation (NEOG) Operating cash flow
Neogen Corporation's operating cash flow for fiscal 2026 was $83.2M, up 43.0% from $58.2M in fiscal 2025. Over the twelve months to 31 August 2026 it was $85.3M. Over the past ten years it has ranged from $35.3M (fiscal 2024) to $85.9M (fiscal 2020); the current reading is higher than 92% of that period. Neogen Corporation ranks 29th of 149 Medical Devices companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2026 | $83.2M | 42.96% |
| FY2025 | $58.2M | 64.87% |
| FY2024 | $35.3M | (13.96%) |
| FY2023 | $41.0M | (39.70%) |
| FY2022 | $68.0M | (16.09%) |
| FY2021 | $81.1M | (5.58%) |
| FY2020 | $85.9M | 34.52% |
| FY2019 | $63.8M | (7.65%) |
| FY2018 | $69.1M | 14.69% |
| FY2017 | $60.3M | 70.60% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Aug 2026 | $12.9M | (57.28%) |
| May 2026 | $30.2M | 33.02% |
| Feb 2026 | $22.7M | 16.44% |
| Nov 2025 | $19.5M | 80.53% |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| ITGR Integer Holdings Corporation compare | $176.5M |
| INSP Inspire Medical Systems, Inc. compare | $135.0M |
| TMDX TransMedics Group, Inc. compare | $112.4M |
| NEOG Neogen Corporation | $85.3M |
| UFPT UFP Technologies, Inc. compare | $71.6M |
| AXGN AxoGen, Inc. compare | $28.4M |
| BFLY Butterfly Network, Inc. compare | −$23.4M |
| ESTA Establishment Labs Holdings Inc. compare | −$32.3M |
| ALMR Alamar Biosciences, Inc. compare | −$100.0M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on NEOG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement